Background: Implantable defibrillators are recommended for the prevention of sudden
cardiac death in patients with heart failure. However, criteria to identify those who would …

Sudden death is a major cause of mortality in patients with ventricular dysfunction. The
highest risk occurs among patients with less severe functional impairment. Current methods …

Objectives: To investigate the generalizability of the reduction in mortality posed by
implantable cardioverter-defibrillators, we examined the effectiveness of defibrillators as …

Sudden cardiac death (SCD) may occur in as many as 40% of all patients who suffer from
heart failure. This review describes the scope of the problem, risk factors for SCD, the effect …

Numerous trials have demonstrated survival benefits using implantable cardioverter
defibrillators (ICDs) for primary prevention in selected patients with left ventricular (LV) …

Multiple clinical trials support the use of implantable cardioverter-defibrillators (ICDs) for
prevention of sudden cardiac death in patients with heart failure (HF). Unfortunately, several …

Abstract Background Despite ACC/AHA guidelines indicating implantable cardioverter
defibrillator (ICD) as class I therapy for primary prevention of sudden cardiac death in …

Objectives This study was designed to delineate the role of implantable cardioverter
defibrillator (ICD) therapy for the primary and secondary prevention of sudden cardiac death …

This clinical perspective addresses the practical aspects of the decision to implant an
implantable cardioverter-defibrillator (ICD) for primary prevention of sudden death in …

Background Patients with heart failure who receive an implantable cardioverter–defibrillator
(ICD) for primary prevention (ie, prevention of a first life-threatening arrhythmic event) may …